Product Images Enoxaparin Sodium

The text is a description of Enoxaparin Sodium Injection, USP. It comes in a single-dose syringe with an automatic safety device for subcutaneous use. Each syringe has 100mg of enoxaparin sodium injection, USP derived from porcine intestinal mucosa in water for the injection. Dosage and Administration instructions are provided. Each 0.025 mL graduation equals 2.5 mg enoxaparin sodium injection, USP. The text contains warnings about keeping the product out of reach of children and instructions for storage at specific temperatures. The product is distributed by Hepalink USA Inc.*

This is a product description for Enoxaparin Sodium Injection, a medication used for subcutaneous injection, available in single-dose syringes that comes with automatic safety device. Each syringe contains 100 mg enoxaparin sodium injection, USP. The product is distributed by Hepalink USA Inc., and originated from China. It is important to follow the prescribing information and instructions for use. The product should be stored at a controlled room temperature, and kept out of reach of children. Graduations of 0.025 mL equals to 2.5 mg enoxaparin sodium injection.*

This is a description for a medication called Enoxaparin Sodium Injection, USP. It is supplied in a concentration of 100 mg/1 mL by a company named Techdow. The medication is intended for subcutaneous injection and comes with an expiration date of 102/2023. The NDC number for the medication is 81952-130-01 and it appears to be available only with a prescription (notated by the "R only" designation).*

This text is describing a medication called Enoxaparin Sodium Injection, USP in a concentration of 120 mg/0.8 mL. The medication is intended to be used subcutaneously, and it comes as a single-dose syringe that features an automatic safety device. Each syringe contains 120 mg enoxaparin derived from porcine intestinal mucosa in water for injection. The text also includes dosage and administration instructions and warnings, including the need for the medication to be kept away from children, and storage requirements at room temperature between 15°C-30°C (59°F-86°F). The medication is distributed by Hepalink USA Inc.*

This is a description for a medication called "Enoxaparin Sodium Injection, USP." It is a subcutaneous medication with an automatic safety device. It is sold in 10 single-dose syringes, each containing 120 mg of Enoxaparin Sodium Injection. Each syringe is derived from porcine intestinal mucosa in Water for Injection. It contains warnings regarding keeping it out of reach from children and storage instructions. The medication is distributed by Hepalink USA Inc and the country of origin is China. The text also includes specific information about dosage, administration, and grading.*

This is a label for Enoxaparin Sodium Injection, which is an anticoagulant medication used to prevent blood clots. The medication comes in a 120mg/0.8mL dosage, intended for subcutaneous injection. The listed NDC number is 81952-132-18 and the manufacturer appears to be Techdow. The label also includes spaces to fill in a lot number and expiration date.*

This is a description of Enoxaparin Sodium Injection, USP which is available in one 1 mL single-dose syringe with automatic safety device for subcutaneous use. Each syringe contains 150 mg of enoxaparin sodium injection, USP derived from porcine intestinal mucosa in Water for Injection. Each 0.02 mL graduation equals 3 mg enoxaparin sodium injection. It is important to keep it out of reach of children and store it at 25°C (77°F), with permitted excursions to 15°C-30°C (59°F-86°F) according to USP Controlled Room Temperature. It should be stored in the original packaging until ready for use. The product is distributed by Hepalink USA Inc. The issuing date is 02/2023.*

Enoxaparin Sodium Injection, USP is a medication used for subcutaneous use. It comes in 1mL single-dose syringes with automatic safety devices. The dosage and administration should follow prescribed information and instructions for use. The medication should be kept out of the reach of children and stored at 25°C (77°F) with permitted excursions to 15°C-30°C (59°F-86°F) in the original packaging until use. The syringe contains 150 mg enoxaparin sodium injection, USP derived from porcine intestinal mucosa in Water for Injection. The manufacturer is Hepalink USA Inc. The text seems to be a product label.*

This is a description of Enoxaparin Sodium Injection, USP identified by NDC 81952-135.01 manufactured in CHINA for Hepalink USA Inc. The suggested use is for subcutaneous injection and the expiry date is 102/2023. However, there is no information about the LOT and EXP.*

This is a description of the drug Enoxaparin Sodium Injection, USP, provided in various codes and numbers of the product package. It also contains information on usage instructions, storage, and warnings. This drug is available in a pre-filled syringe, which contains 30 mg of the injection, to be administered subcutaneously. The drug is derived from porcine intestine mucosa in water for injection. The user must take precautions to keep the drug out of reach of children and store it between 15°C-30°C. The packaging has been supplied by Hepalink USA Inc.*

This is a product description for Enoxaparin Sodium Injection, USP with NDC 81952-123-23. The injection is for subcutaneous use and is available in ten 0.3mL single-dose syringes with automatic safety devices. Each syringe contains 30mg enoxaparin sodium injection derived from porcine intestinal mucosa in water for injection. Dosage and administration should be based on the prescribing information and instructions for use. The warning label indicates that it should be kept out of reach of children and stored in the original packaging at 25°C (77°F) with excursions allowed between 15°C to 30°C (59°F to 86°F). It is distributed by Hepalink USA Inc. and originates from China.*

This is a product description for Enoxaparin Sodium Injection. It has a National Drug Code (NDC) of 81952-123-13 and the medication is available only with a prescription (Rx only). The injection contains 30mg of enoxaparin sodium in 0.3 mL, and is intended for subcutaneous injection. The mention of "@Techdow" is unclear and may not be relevant to the product description.*

Enoxaparin Sodium Injection is a USP prescription medication given to patients subcutaneously. The medication comes in a 40 mg/0.4 mL bottle that contains enoxaparin sodium injection, USP derived from porcine iestinal mcosa inWater for njoction. Each single-dose syringe has a 0.4 mL volume and an automatic safety device to prevent accidents during use. Dosage and Administration instructions come with each box. The medication must be kept out of children's reach and stored at temperatures between 15°C-30°C (50°F-86°F). Packaging or cartons must be kept until the patient is ready to use.*

A medication called Enoxaparin Sodium Injection, USP is available in 0.4 mL single-dose syringes with an automatic safety device. Each syringe contains 40 mg of the drug. It is intended for subcutaneous use only. The product is distributed by Hepalink USA Inc. and the packaging is manufactured by Techdow, a Hepalink Company. Dosage and administration instructions are listed on the packaging. It is suggested to store the medication at 25°C or room temperature, and out of the reach of children. The product was made in China and issued in February 2023.*

This is a description of a medication with the National Drug Code (NDC) 81952-124.14 R. The medication is Enoxaparin Sodium Injection, USP containing 40 mg/0.4 mL, manufactured in China for Hepalink USA Inc. The medication is meant for subcutaneous injection and the expiration date is 102/2023 without a lot number provided.*

This is a description of the Enoxaparin Sodium Injection, USP, which is a medicine used subcutaneously. The injection has a single-dose syringe with an automatic safety device. The injection contains 60 mg enoxaparin sodium derived from porcine mucosa in water for injection. Each 0.025 mL graduation equals 2.5 mg enoxaparin sodium injection. Users should refer to the prescribing information and instructions for use before administering the drug. Store the injection in the original carton or packaging until ready to use at 25°C (77°F), with excursions permitted to 15°C-30°C (59°F-86°F). Keep out of reach of children. The injection is distributed by Hepalink USA Inc, Langhorne, PA. The issued date is 02/2023.*

The text describes a medication called Enoxaparin Sodium Injection, USP used for subcutaneous use that comes in Ten 0.6 mL single-dose syringes with an automatic safety device. Each syringe contains 60 mg enoxaparin sodium injection, USP derived from porcine intestinal mucosa in Water for Injection. The dosage and administration must be consulted in the prescribing information and instructions for use. The medication must be kept out of reach of children and stored at 25°C (77°F), with excursions permitted to 15°C-30°C (59°F-86°F). The original carton or packaging must be kept until the medication is ready to use. The medication is distributed by Hepalink USA Inc., and the batch number is not readable.*

This text provides information about a medication called Enoxaparin Sodium Injection, USP, which has an NDC code of 81952-126-16, a strength of 160 mg/0.6 mL, and is intended for subcutaneous injection. The medication was manufactured in China for Hepalink USA Inc. Unfortunately, there is no additional information available from the text.*

This is a description of a medication called Enoxaparin Sodium Injection, USP. It comes in a single-dose syringe of 0.8 mL with automatic safety device containing 80 mg of enoxaparin sodium injection, USP derived from porcine intestinal mucosa in Water for Injection. Each 0.025 mL graduation equals 2.5 mg of enoxaparin sodium injection, USP. It is used for subcutaneous use and dosage and administration instructions should be followed. It warns to keep out of reach of children and should be stored at room temperature. It is distributed by Hepalink USA Inc. The expiration date is 02/2023.*

This is a description of a medication called Enoxaparin Sodium Injection, USP, with an NDC number of 81952-128-28, manufactured by Techdow, a Hepalink company. It is available in single-use syringes of 0.8ml with a safety device. Each syringe contains 80mg of Enoxaparin Sodium Injection, USP derived from porcine intestinal mucosa in Water for Injection. The medication is intended for subcutaneous use and has dosage and administration instructions. The medication must be kept in its original packaging until use and should be stored at controlled room temperature, between 15°C-30°C (59°F-86°F). The medication is distributed in the USA by Hepalink USA Inc.*

This is a description of medication with NDC number 81952-128-18, which is enoxaparin sodium injection. It can be administered subcutaneously by injection and appears to be manufactured by Hepalink USA Inc. The source of this information appears to be Techdow.*

This looks like a table with information about patients and different factors such as sex, age, infarct location, and treatment options. It includes the number of patients in each group and their relative risk of certain outcomes, although it is not clear what those outcomes are without additional context.*

This appears to be a statistical analysis report presenting a hazard distribution function and a LG rank test. It further shows numerical data related to Enoxaparin and Enonaparin, including time to death or myocardial re-infarction and the number at risk.*